JENIFER PETERS: Open Payments
NPI 1023046380 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,008 in 144 payments from 17 companies in 2025. Trend: 2023 $1,679 · 2024 $2,246 · 2025 $3,008
Food & beverage: $3,008
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $681 |
| GlaxoSmithKline, LLC. | 30 | $379 |
| GENZYME CORPORATION | 24 | $330 |
| CSL Behring | 14 | $323 |
| PFIZER INC. | 12 | $212 |
| Novartis Pharmaceuticals Corporation | 9 | $205 |
| Regeneron Healthcare Solutions, Inc. | 8 | $180 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $179 |
| ABBVIE INC. | 12 | $165 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $95 |
Products named: DUPIXENT, NUCALA, FASENRA, Hizentra, BREZTRI, NEFFY, AIRSUPRA, RINVOQ.
Industry payments across SC — which companies pay providers there.
